Richard William Scalzo sold $10K of CBIO stock

Richard William Scalzo, Chief Financial Officer of Crescent Biopharma, Inc. (CBIO), sold 568 shares of CBIO stock worth $10K, per an SEC Form 4 filed Sep 18, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 16, 2026, 2 days before it was made public.

CBIO has moved -21.2% since the trade date, from $17.18 to $13.54 (Nov 6, 2026 close).